Dihydroergotamine mesylate
HealthData.Gov
Updated Mar 24, 2026
About this dataset
Dihydroergotamine Mesylate is a prescription injectable medication used to treat migraine headaches. It works by narrowing blood vessels in the brain to relieve pain. Available as a 1 mg/mL solution in vials, it's administered via intramuscular, intravenous, or subcutaneous injection by healthcare professionals. Manufactured by Sagent Pharmaceuticals under ANDA207264. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Dihydroergotamine mesylate
Access the FDA dataset for Dihydroergotamine mesylate β ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025